Evidence map›Paper›PMID 41374402›Full record

ArticleDiagnostics (Basel, Switzerland)2025

Overexpression of

Xuejian Yang, Yunjie Guo, Lanyu Wang, Zengli Miao, Xiaojie Lu, Jun Ruan, Wei Tian

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. The Stalk Sign in Bladder Cancer: CEUS Versus MRI.Diagnostics (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xuejian YangDepartment of Urology, Suqian First Hospital, Suqian 223800, China.
Yunjie GuoDepartment of Urology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi 214000, China.ORCID 0000-0003-0983-9227
Lanyu WangThe First Affiliated Hospital of Nanchang University, Nanchang 330000, China.
Zengli MiaoDepartment of Neurosurgery, Jiangnan University Medical Center (The Affiliated Wuxi No. 2 People's Hospital), Wuxi 214000, China.
Xiaojie LuDepartment of Neurosurgery, Jiangnan University Medical Center (The Affiliated Wuxi No. 2 People's Hospital), Wuxi 214000, China.
Jun RuanDepartment of Urology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi 214000, China.
Wei TianDepartment of Neurosurgery, Jiangnan University Medical Center (The Affiliated Wuxi No. 2 People's Hospital), Wuxi 214000, China.

Funding

Suqian Sci&Tech Program K202321Wuxi Taihu Lake Talent Plan, Supports for Leading Talents in Medical and Health Profession ZDXK2021004
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bioinformatics analysisbiomarkerbladder cancercancer progressionCDC20

Identifiers

PMID41374402
PMCPMC12691489

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.